Aeglea BioTherapeutics, Inc. (AGLE) - Balance Sheet Statement

Home
AGLE
Financials

12.01 (USD) • At close November 27, 2023

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	34.863	15.142	90.095	19.253	22.461	12.817	47.748	29.294	2.616	4.597
Short Term Investments Numbers are in millions	20.848	77.986	56.178	52.696	52.052	37.482	15.754	3.768	0	0
Cash and Short Term Investments Numbers are in millions	55.711	93.128	146.273	71.949	74.513	50.299	63.502	33.062	2.616	4.597
Net Receivables Numbers are in millions	0.375	0.815	0	0	0	3.078	1.215	1.697	0	0
Inventory Numbers are in millions	0	-0.815	0	0	0	0	0	0	0	0
Other Current Assets Numbers are in millions	6.172	5.763	3.516	2.556	2.158	0	0	0	0	0
Total Current Assets Numbers are in millions	62.258	98.891	149.789	74.505	76.671	54.991	66.424	38.286	2.73	4.597
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	6.65	8.355	9.872	7.111	1.018	0.854	0.599	0.348	0.162	0
Goodwill Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Long Term Investments Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Tax Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	2.236	2.68	1.957	1.567	0.05	0.232	0.04	0.02	0.038	0
Total Non-Current Assets Numbers are in millions	8.886	11.035	11.829	8.678	1.068	1.086	0.639	0.368	0.2	0
Total Assets Numbers are in millions	71.144	109.926	161.618	83.183	77.739	56.077	67.063	38.654	2.93	4.597
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	0.677	3.319	2.254	3.154	0.663	0.389	0.168	0.176	0.319	0.217
Short Term Debt Numbers are in millions	0.625	0.436	0.319	0.351	0	5.061	3.499	0	0	0
Tax Payables Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Numbers are in millions	0.517	2.359	13.406	14.385	0	0.02	0.071	0	0	0
Other Current Liabilities Numbers are in millions	12.837	14.03	0.464	0.469	9.576	5.22	3.726	2.347	0.739	1.195
Total Current Liabilities Numbers are in millions	14.656	20.144	16.443	18.359	10.239	5.629	3.965	2.523	1.058	1.412
Non-Current Liabilities:
Long Term Debt Numbers are in millions	4.004	4.608	5.129	4.712	0	0	0	0	0	0
Deferred Revenue Non-Current Numbers are in millions	2.179	1.217	0	0	0	0	0	0	0	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities Numbers are in millions	0	0.016	0.214	0.031	0.072	0.111	0.132	0.027	0	0
Total Non-Current Liabilities Numbers are in millions	6.183	5.841	5.343	4.743	0.072	0.111	0.132	0.027	0	0
Total Liabilities Numbers are in millions	20.839	25.985	21.786	23.102	10.311	5.74	4.097	2.55	1.058	1.412
Equity:
Preferred Stock Numbers are in millions	0	0	0	0	0	0	0	0	13.345	4.458
Common Stock Numbers are in millions	0.006	0.005	0.005	0.003	0.002	0.002	0.001	0.001	0.811	0.664
Retained Earnings Numbers are in millions	-425.624	-341.809	-276.008	-195.115	-116.861	-72.513	-45.277	-23.579	-12.284	-1.937
Accumulated Other Comprehensive Income/Loss Numbers are in millions	-0.048	-0.02	0.011	0.051	-0.027	-0.102	-0.004	-0.001	0	0
Other Total Stockholders Equity Numbers are in millions	475.971	425.765	415.824	255.142	184.314	122.95	108.246	59.683	0	0
Total Shareholders Equity Numbers are in millions	50.305	83.941	139.832	60.081	67.428	50.337	62.966	36.104	1.872	3.185
Total Equity Numbers are in millions	50.305	83.941	139.832	60.081	67.428	50.337	62.966	36.104	1.872	3.185
Total Liabilities & Shareholders Equity Numbers are in millions	71.144	109.926	161.618	83.183	77.739	56.077	67.063	38.654	2.93	4.597

Aeglea BioTherapeutics, Inc.

NASDAQ:AGLE Add to watchlist

NASDAQ:AGLE